Saturday, October 2, 2010

American Conference Institute Biotech Patents Conference

American Conference Institute (ACI) will be holding its 12th Advanced Forum on Biotech Patents on November 30 to December 1, 2010 in Boston, MA.  The conference will allow attendees to:
• Adopt a practical approach to incorporate follow-on biologics into your current patent portfolio and brace for the flood of litigation anticipated in the wake of the new legislation;
• Implement strategies to draft and protect diagnostic claims in the wake of Bilski and its progeny;
• Analyze the potential ramifications of Myriad and build fallback positions to protect your claims in light of the attack on the patentability of genes;
• Draft strong claims in compliance with how Courts are applying the standards for written description and enablement set forth in Ariad;
• Incorporate the new PTO initiatives to streamline the patent approval process and anticipate potential challenges during examination;
• Develop global prosecution and litigation strategies to minimize risk and maximize profit in the EU and emerging markets in China and India;
• Assess post-KSR case law developments and tailor your claims to fall within the increasingly strict standards for obviousness;
• Determine standards for materiality and intent to avoid inequitable conduct charges in light of the Therasense decision; and
• Defend and protect IP against third-party infringement.

In particular, ACI's faculty will offer presentations on the following topics:
• Follow-on biologics:  Dissecting the legal, scientific and commercial realities of biosimilars and their impact on patent strategies;
• The future of diagnostic method patents:  Examining and analyzing the criteria for patentability handed down by the Supreme Court inBilski -- to be presented in part by Patent Docsauthor Kevin Noonan;
• Examining the new PTO initiatives:  How to benefit from the PTO's initiatives to eliminate backlog -- keynote by Sharon Barner, Deputy Director of the U.S. Patent and Trademark Office;
• Focus on China and India:  Breaking Into and securing enforcement of biotechnology IP in burgeoning superpower economies;
• Developing key practice strategies for the European Union;
• Are genes patentable?  Examining the potential ramifications of Myriadand developing practical strategies to protect your IP;
• Uncovering potential inventorship issues and resolving ownership uncertainties;
• The art of prior art:  Avoiding inequitable conduct claims through proactive drafting and disclosure;
• Navigating the intricacies of PTO patent practice;
• Antibodies:  Overcoming patentability hurdles and claim drafting strategies for new technological developments; and
• Overcoming ethical and practical challenges when patenting cutting edge technologies.
An additional master class entitled: "Drafting and Prosecuting Successful Patent Applications in the US and Abroad in an Evolving Biotech Patent Landscape" will be offered from 9:00 am to 12:30 pm on December 2, 2010.
The agenda for the Biotech Patents conference can be found here.  A complete brochure for this conference, including an agenda, detailed descriptions of conference sessions, list of speakers, and registration form can be obtainedhere.
ACI - American Conference InstituteThe registration fee ranges from $2,295 (conference) to $2,895 (conference plus master class).  Those registering on or before October 29, 2010 will receive a $200 discount.  Those interested in registering for the conference can do so here, by calling 1-888-224-2480, or by faxing a registration form to 1-877-927-1563.

No comments:

Post a Comment